CatalystPit

NSRXNasus Pharma Ltd

NYSE · Pharmaceutical Preparations
Last close $3.69 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-06-22 · Teleman Dan Benjamin (Chief Executive Officer) · BUY
  • 2026-04-22 · Teleman Dan Benjamin (Chief Executive Officer) · BUY
  • 2026-04-01 · Teleman Dan Benjamin (Chief Executive Officer) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders10
Shares held2,150,411
Value$7.53M
As of quarter end2026-06-30
RECENT NEWS
  • Nasus Pharma stock reiterated at Market Outperform by Citizens
  • Nasus Pharma enrolls first patient in Phase 1 study of NS003
  • Nasus Pharma wins FDA approval
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Nasus Pharma Ltd (NSRX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit